Results 161 to 170 of about 1,753,525 (297)
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
For better repute in software monopoly, quality of product is one of the essential factors in any corporation. Quality of the product depends on the satisfaction of customer. Product quality is measured by customer satisfaction with that product.
Inam Ul Haq+3 more
doaj
Current Trends and Future Directions of Digital Pathology and Artificial Intelligence in Dermatopathology: A Scientometric-Based Review. [PDF]
Cocuz IG+9 more
europepmc +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
Crude Oil Yield Estimation: Recent Advances and Technological Progress in the Oil Refining Industry. [PDF]
Wan Jusoh WNL+4 more
europepmc +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source
The software configuration management system for image processing algorithm development
Jeongheon Lee, Oksam Chae
openalex +2 more sources
An analysis method for improving a bug modification process in open source software development [PDF]
Akinori Ihara+2 more
openalex +1 more source
We investigated whether hypomethylating agents (HMAs) used in myeloid malignancies induce somatic retrotransposition. Our findings indicate that HMA treatment increases L1‐encoded protein expression but does not lead to detectable de novo retrotransposition events in either patient samples or cell lines.
Šárka Pavlová+14 more
wiley +1 more source